Finding, Linda told us at the annual meeting, in answer to my question, that they were almost at the total number for full enrollment in DCVaxL. While she didn't come out and say it, she agreed with my comments that they have a three month enrollment pipeline, where patients need to take the standard of care treatment and go through blood draws. She also agreed that a large number of patients end up In the parallel trial because they are rapid professors or pseudo progressors, so they don't end up in the Ph III trial .
It is my personal opinion that they missed by a few patients. If that's the case, they probably have already enrolled those few patients, plus a few more, and we will see enrollment reached 3 months from when they realized they had missed,... Maybe February. And then We will get the PR. I should have asked; I was more than a bit surprised that she acknowledged that they were almost at the total
This is unlikely to change the completion date of the trial by more than a month, if that. And she's already acknowledged that.
Market Data 
Markets 
AI
